BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 26006050)

  • 21. PI31 is a modulator of proteasome formation and antigen processing.
    Zaiss DM; Standera S; Kloetzel PM; Sijts AJ
    Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14344-9. PubMed ID: 12374861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leucine aminopeptidase is not essential for trimming peptides in the cytosol or generating epitopes for MHC class I antigen presentation.
    Towne CF; York IA; Neijssen J; Karow ML; Murphy AJ; Valenzuela DM; Yancopoulos GD; Neefjes JJ; Rock KL
    J Immunol; 2005 Nov; 175(10):6605-14. PubMed ID: 16272315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of the role of bleomycin hydrolase in antigen presentation and the generation of CD8 T cell responses.
    Towne CF; York IA; Watkin LB; Lazo JS; Rock KL
    J Immunol; 2007 Jun; 178(11):6923-30. PubMed ID: 17513741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytosolic aminopeptidases influence MHC class I-mediated antigen presentation in an allele-dependent manner.
    Kim E; Kwak H; Ahn K
    J Immunol; 2009 Dec; 183(11):7379-87. PubMed ID: 19917696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of tripeptidyl peptidase II in MHC class I antigen processing - the end of controversies?
    Endert Pv
    Eur J Immunol; 2008 Mar; 38(3):609-13. PubMed ID: 18286570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The ongoing saga of the mechanism(s) of MHC class I-restricted cross-presentation.
    Grotzke JE; Sengupta D; Lu Q; Cresswell P
    Curr Opin Immunol; 2017 Jun; 46():89-96. PubMed ID: 28528219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct proteolytic processes generate the C and N termini of MHC class I-binding peptides.
    Mo XY; Cascio P; Lemerise K; Goldberg AL; Rock K
    J Immunol; 1999 Dec; 163(11):5851-9. PubMed ID: 10570269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of the role of tripeptidyl peptidase II in MHC class I antigen presentation in vivo.
    Kawahara M; York IA; Hearn A; Farfan D; Rock KL
    J Immunol; 2009 Nov; 183(10):6069-77. PubMed ID: 19841172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of serine-peptidase activity enhances the generation of a survivin-derived HLA-A2-presented CTL epitope in colon-carcinoma cells.
    Preta G; Marescotti D; Fortini C; Carcoforo P; Castelli C; Masucci M; Gavioli R
    Scand J Immunol; 2008 Dec; 68(6):579-88. PubMed ID: 19000094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A major role for TPPII in trimming proteasomal degradation products for MHC class I antigen presentation.
    Reits E; Neijssen J; Herberts C; Benckhuijsen W; Janssen L; Drijfhout JW; Neefjes J
    Immunity; 2004 Apr; 20(4):495-506. PubMed ID: 15084277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Re-evaluating the generation of a "proteasome-independent" MHC class I-restricted CD8 T cell epitope.
    Wherry EJ; Golovina TN; Morrison SE; Sinnathamby G; McElhaugh MJ; Shockey DC; Eisenlohr LC
    J Immunol; 2006 Feb; 176(4):2249-61. PubMed ID: 16455981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequence-specific alterations of epitope production by HIV protease inhibitors.
    Kourjian G; Xu Y; Mondesire-Crump I; Shimada M; Gourdain P; Le Gall S
    J Immunol; 2014 Apr; 192(8):3496-506. PubMed ID: 24616479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. No essential role for tripeptidyl peptidase II for the processing of LCMV-derived T cell epitopes.
    Basler M; Groettrup M
    Eur J Immunol; 2007 Apr; 37(4):896-904. PubMed ID: 17357105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunology. Nothing 'gainst time's scythe can make defense..
    Ploegh HL
    Science; 2004 May; 304(5675):1262-3. PubMed ID: 15166355
    [No Abstract]   [Full Text] [Related]  

  • 35. Mouse Norovirus Infection Reduces the Surface Expression of Major Histocompatibility Complex Class I Proteins and Inhibits CD8
    Fritzlar S; Jegaskanda S; Aktepe TE; Prier JE; Holz LE; White PA; Mackenzie JM
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29976673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Producing nature's gene-chips: the generation of peptides for display by MHC class I molecules.
    Shastri N; Schwab S; Serwold T
    Annu Rev Immunol; 2002; 20():463-93. PubMed ID: 11861610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Degradation of cell proteins and the generation of MHC class I-presented peptides.
    Rock KL; Goldberg AL
    Annu Rev Immunol; 1999; 17():739-79. PubMed ID: 10358773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced delivery of exogenous peptides into the class I antigen processing and presentation pathway.
    De Haan L; Hearn AR; Rivett AJ; Hirst TR
    Infect Immun; 2002 Jun; 70(6):3249-58. PubMed ID: 12011020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generating MHC class I ligands from viral gene products.
    Yewdell J; Antón LC; Bacik I; Schubert U; Snyder HL; Bennink JR
    Immunol Rev; 1999 Dec; 172():97-108. PubMed ID: 10631940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple proteases process viral antigens for presentation by MHC class I molecules to CD8(+) T lymphocytes.
    Del-Val M; López D
    Mol Immunol; 2002 Oct; 39(3-4):235-47. PubMed ID: 12200053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.